Evidence map›Paper›PMID 27145697›Full record

ReviewMedical science monitor basic research2016

Concurrent Left Ventricular Assist Device (LVAD) Implantation and Percutaneous Temporary RVAD Support via CardiacAssist Protek-Duo TandemHeart to Preempt Right Heart Failure.

Bastian Schmack, Alexander Weymann, Aron-Frederik Popov, Nikhil Prakash Patil, Anton Sabashnikov, Jamila Kremer, Mina Farag, Andreas Brcic, Christoph Lichtenstern, Matthias Karck and 1 more

Abstract readReview
In one paragraph

Review in Medical science monitor basic research, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Review
  4. Novel Therapies for Right Ventricular Failure.Current cardiology reports · 2025
    Review
  5. Review
  6. Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Review
  12. The ProtekDuo for percutaneous V-P and V-VP ECMO in patients with COVID-19 ARDS.The International journal of artificial organs · 2022
    Observational
  13. Article
  14. Review
  15. Review
  16. Article
  17. Echocardiography for extracorporeal membrane oxygenation.Echocardiography (Mount Kisco, N.Y.) · 2022
    Review
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Bastian SchmackDepartment of Cardiac Surgery, Heart Centre, University Hospital Heidelberg, Heidelberg, Germany.
Alexander WeymannDepartment of Cardiac Surgery, Heart Centre, University Hospital Heidelberg, Heidelberg, Germany.
Aron-Frederik PopovDepartment of Cardiothoracic Transplantation & Mechanical Circulatory Support, Royal Brompton and Harefield NHS Foundation Trust, London, United Kingdom.
Nikhil Prakash PatilDepartment of Cardiothoracic Transplantation & Mechanical Circulatory Support, Royal Brompton and Harefield NHS Foundation Trust, London, United Kingdom.
Anton SabashnikovDepartment of Cardiothoracic Transplantation & Mechanical Circulatory Support, Royal Brompton and Harefield NHS Foundation Trust, London, United Kingdom.
Jamila KremerDepartment of Cardiac Surgery, Heart Centre, University Hospital Heidelberg, Heidelberg, Germany.
Mina FaragDepartment of Cardiac Surgery, Heart Centre, University Hospital Heidelberg, Heidelberg, Germany.
Andreas BrcicDepartment of Anaesthesiology, University Hospital Heidelberg, Heidelberg, Germany.
Christoph LichtensternDepartment of Anaesthesiology, University Hospital Heidelberg, Heidelberg, Germany.
Matthias KarckDepartment of Cardiac Surgery, Heart Centre, University Hospital Heidelberg, Heidelberg, Germany.
Arjang RuhparwarDepartment of Cardiac Surgery, Heart Centre, University Hospital Heidelberg, Heidelberg, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Right ventricular failure (RVF) is an unfortunate complication that continues to limit outcomes following durable left ventricular assist device (LVAD) implantation. Despite several 'RVF risk scores' having been proposed, preoperative prediction of post-LVAD RVF remains a guesstimate at best. Current strategies for institution of temporary RVAD support are invasive, necessitate additional re-thoracotomy, restrict postoperative mobilization, and/or entail prolonged retention of prosthetic material in-situ. The authors propose a novel surgical strategy comprising simultaneous implantation of a permanent LVAD and percutaneous TandemHeart® plus ProtekDuo® to provide temporary RVAD support and preempt RVF in patients with impaired RV function.

Indexed as

Heart-Assist DevicesCardiac Surgical ProceduresHeart FailureHumansRetrospective StudiesTreatment OutcomeVentricular Dysfunction, LeftVentricular Dysfunction, Right

Identifiers

PMID27145697
PMCPMC4913730

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.